ABOUT US

meet us at
3rd - 6th MAY 2010
BIO 2010 CHICAGO - USA

LAST NEWS
Nov 2009 - DSM/Galenix strategic alliance

Galenix out-licenses drug delivery technologies to DSM Pharmaceutical Products and forms in a strategic alliance : Galenix today announced that it has out-licensed six drug delivery technologies to DSM Pharmaceutical Products, Parsippany, USA. Galenix and DSM have also agreed on a manufacturing alliance, where DSM will be the preferred commercial scale manufacturing partner for Galenix commercial products on a global basis. Galenix and DSM will collaborate on business development opportunities co-marketing the technologies based on the strength of Galenix in drug product development and clinical services, and DSM in process development, industrial scale up and commercial pharmaceutical manufacturing.
2009 - cGMP Agreement for human use

Galenix Pharma has obtained an updated agreement for cGMP manufacturing, importation and ditribution of human and investigational medicinal products AFSSAPS #M09/168
2008 - cGMP Agreement for veterinary use

Galenix Pharma has obtained an agreement for cGMP manufacturing, importation and distribution of veterinary and investigational medicinal products AFSSA #V1515/08

newsletter signup
Subscribe Newsletter Please insert your email adress


indentification user
Forgot password Register

  • Founded in 1993
  • 100% privately owned
  • CEO and main shareholder: Mr Jerome Besse
  • 70 employees
  • Turn over 2008: 13.8 MEuros
  • Three entities:
    • - Galenix Innovations
    • - Galenix Pharma
    • - Galenix Inc.
Services provided to health and biotech companies:

  • Patented Drug Delivery Systems for licensing out
  • Preformulation Products Registration Files for licensing out
  • Formulation development
  • Analytical development and validation
  • Quality Control
  • Stability studies
  • Clinical/pilot batches manufacturing and packaging
  • Clinical packaging and distribution
  • Regulatory affairs
    		•
    Board of Directors and Scientific Advisory Board:
    Jerome BESSE Legal Representative jbesse@galenix.fr
    Celine PULON Pharmaceutical Affairs Director cpulon@galenix.fr
    Nicolas MOINAUX Chief Financial Officer nmoinaux@galenix.fr
    Marie-Laure LEICHTNAM Plant Director (Ad Interim) - QP mlleichtnam@galenix.fr
    Laurence BESSE Pharmaceutical R&D Director lbesse@galenix.fr
    Facts:
  • CA = 13.8 M €
  • Services :
      - Drug Product Development
      - Drug Delivery Solutions
      - Clinical supply services



    • Home - About us - Pharmaceutical Services - Clinical Supplies - Drug delivery - Business Opportunities - News - Job offers - Contact
    Copyright © 2010 Galenix - Tous droits réservés